Results 161 to 170 of about 17,928 (186)
Randomized clinical trial for pop titrated versus the slow coagulation cyclophotocoagulation in treating dark irises neovascular glaucoma. [PDF]
Kiddee W +3 more
europepmc +1 more source
Treatment outcomes of paul versus ahmed glaucoma implants. [PDF]
Prinz J +5 more
europepmc +1 more source
Macular Edema in Diabetic Neovascular Glaucoma and Its Association with Systemic Diseases. [PDF]
Kang K, Kang KT, Kim YC.
europepmc +1 more source
GLP-1 receptor agonists in eye disease: a comprehensive review of current research and future potential. [PDF]
Luo Y +5 more
europepmc +1 more source
Predicting visual acuity using optical coherence tomography in patients with neovascular age-related macular degeneration. [PDF]
Moon S +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Glaucomas: Neovascular Glaucoma
2009Topical and oral medical therapies are the initial treatment of choice to lower intraocular pressure (IOP) and limit vision loss and pain secondary to neovascular glaucoma (NVG).
Adam S. Wenick, Alan L. Robin
openaire +1 more source
Neovascular Glaucoma. Current Management
Retina, 1981Neovascular glaucoma is one the most difficult forms of glaucoma to treat successfully. Recent advances modifying filtration surgery can result in up to 77% success. Utilization of anterior and posterior segment photocoagulation can maintain an open angle in up to 80% of eyes when they are treated prior to angle closure by peripheral anterior synechiae.
openaire +2 more sources
Neovascular Glaucoma: An Update
Klinische Monatsblätter für Augenheilkunde, 2022AbstractNeovascular glaucoma (NVG) is a severe type of secondary glaucoma with devastating complications and generally poor visual prognosis. NVG is defined by the development of pathological neovessels over the iris and the iridocorneal angle that can block the outflow of aqueous humor, causing elevation of intraocular pressure (IOP).
Dimitrios Kalogeropoulos +4 more
openaire +2 more sources
Cyclocryotherapy in Neovascular Glaucoma
American Journal of Ophthalmology, 1978To determine the long-term effects of cyclocryotherapy, we conducted a follow-up with a mean of 24.9 +/- 13.9 months in 50 eyes of 46 patients with neovascular glaucoma. On final examination, intraocular pressure in 16 (32%) of the eyes was greater than 26 mm Hg and in 17 (34%), less than or equal to 25 mm Hg; 17 (34%) developed phthisis bulbi ...
T, Krupin, K B, Mitchell, B, Becker
openaire +2 more sources

